2024-04-15

#reports #MTB

[M&T Bank](https://eninvs.com/all.php?name=MTB) (Banking service provider) reported for 2024 q1
(2024-04-15, Before Market Open):

- Revenue -8.3% YoY (vs -5.7% in previous quarter and historical rate +4.8%)
- Net Income -25.6% YoY (vs -37.3% in previous quarter and historical rate +30.3%)
- Net Income margin 31.1% decreased compared to 38.3% same period last year
- P/E multiple is 10.0x compared to historical level (75th percentile) of 11.7x
- P/S multiple is 3.5x
- Price to book: 0.9x

At the opening of the session the share price went up +4.8% vs S&P500 +0.5%

------------------------------------------------

2024-04-12

#reports #WFC

[Wells Fargo](https://eninvs.com/all.php?name=WFC) (Banking service provider) reported for 2024 q1
(2024-04-12, Before Market Open):

- Revenue +0.6% YoY (vs +4.2% in previous quarter and historical rate +2.4%)
- Net Income -7.5% YoY (vs +31.1% in previous quarter and historical rate +39.7%)
- Net Income margin 22.1% decreased compared to 24.1% same period last year
- P/E multiple is 12.3x compared to historical level (75th percentile) of 12.0x
- P/S multiple is 2.8x
- Price to book: 1.2x

At the opening of the session the share price went neutrally vs S&P500 -0.5%

------------------------------------------------

2024-04-12

#reports #BLK

[BlackRock](https://eninvs.com/all.php?name=BLK) (Investments provider ) reported for 2024 q1
(2024-04-12, Before Market Open):

- Revenue +11.4% YoY (vs +6.8% in previous quarter and historical rate +3.7%)
- Net Income +38.8% YoY (vs +13.9% in previous quarter and historical rate +9.1%)
- Net Income margin 34.3% increased compared to 27.6% same period last year
- P/E multiple is 19.0x compared to historical level (75th percentile) of 22.3x
- P/S multiple is 6.4x
- Price to book: 3.0x

At the opening of the session the share price went down -1.4% vs S&P500 -0.5%

------------------------------------------------

2024-04-12

#reports #LOVE

[Lovesac Co/The](https://eninvs.com/all.php?name=LOVE) (Furnishings, Fixtures and Appliances) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165397)
(2024-04-11, Before Market Open):

- Revenue +5.0% YoY (vs +14.1% in previous quarter and historical rate +33.5%)
- EBITDA -10.2% YoY (vs -100.0% in previous quarter and historical rate +1.1%)
- EBITDA margin 17.5% decreased compared to 20.5% same period last year
- Net Debt decreased by $36.0 mln over the past reporting period (11.3% of market cap)
- FCF (LTM) +$0.0 bln (positive), 8.1% of market cap
- EV/EBITDA multiple is 10.5x compared to historical level (75th percentile) of 16.0x
- EV/Sales multiple is 0.6x

The company showed EPS +$1.87 per share. At the opening of the session the share price went down -17.6% vs S&P500 +0.2%

------------------------------------------------

2024-04-11

#reports #STZ

[Constellation Brands](https://eninvs.com/all.php?name=STZ) (Liquor manufacturer) reported for 2024 q1
(2024-04-11, Before Market Open):

- Revenue +7.1% YoY (vs +1.3% in previous quarter and historical rate +7.8%)
- EBITDA +24.4% YoY (vs +4.2% in previous quarter and historical rate +18.8%)
- EBITDA margin 46.0% increased compared to 39.6% same period last year
- Net Debt increased by $12.0 bln over the past reporting period (24.7% of market cap)
- FCF (LTM) +$0.7 bln (positive), 1.4% of market cap
- EV/EBITDA multiple is 15.8x compared to historical level (75th percentile) of 19.0x
- EV/Sales multiple is 5.7x

At the opening of the session the share price went up +1.6% vs S&P500 +0.2%

------------------------------------------------

2024-04-11

#reports #FAST

[Fastenal Co](https://eninvs.com/all.php?name=FAST) (Industrial and building materials supplier) reported for 2024 q1
(2024-04-11, Before Market Open):

- Revenue +1.9% YoY (vs +3.7% in previous quarter and historical rate +9.2%)
- EBITDA -1.1% YoY (vs +5.1% in previous quarter and historical rate +9.0%)
- EBITDA margin 22.7% decreased compared to 23.4% same period last year
- Net Debt decreased by $68.0 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$0.2 bln (positive), 0.4% of market cap
- EV/EBITDA multiple is 24.2x compared to historical level (75th percentile) of 23.8x
- EV/Sales multiple is 5.9x

At the opening of the session the share price went down -5.5% vs S&P500 +0.2%

------------------------------------------------

2024-04-11

#reports #RELL

[Richardson Electronics](https://eninvs.com/all.php?name=RELL) (Electronic Components) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=RELL&q=2024 q1&id=764969)
(2024-04-10, After Market Close):

- Revenue -25.7% YoY (vs -33.3% in previous quarter and historical rate +11.5%)
- EBITDA -77.8% YoY (vs -112.5% in previous quarter)
- EBITDA margin 3.8% decreased compared to 12.9% same period last year
- Net Debt increased by $5.0 mln over the past reporting period (4.5% of market cap)
- FCF (LTM) -$0.0 bln (negative), 5.4% of market cap
- EV/EBITDA multiple is 19.1x compared to historical level (75th percentile) of 12.4x
- EV/Sales multiple is 0.5x

------------------------------------------------

2024-04-10

#reports #WDFC

[WD-40 Co](https://eninvs.com/all.php?name=WDFC) (Lubricant manufacturer) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=WDFC&q=2024 q1&id=711203)
(2024-04-09, After Market Close):

- Revenue +6.9% YoY (vs +12.0% in previous quarter and historical rate +8.6%)
- EBITDA -4.2% YoY (vs +23.8% in previous quarter and historical rate +3.7%)
- EBITDA margin 16.5% decreased compared to 18.5% same period last year
- EV/EBITDA multiple is 34.6x compared to historical level (75th percentile) of 33.7x
- EV/Sales multiple is 6.3x

------------------------------------------------

2024-04-10

#reports #AEHR

[Aehr Test Systems](https://eninvs.com/all.php?name=AEHR) (Semiconductor Equipment and Materials) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=AEHR&q=2024 q1&id=764903)
(2024-04-09, After Market Close):

- Revenue -52.9% YoY (vs +40.0% in previous quarter and historical rate +90.4%)
- EBITDA -150.0% YoY (vs +50.0% in previous quarter)
- EBITDA margin -25.0% decreased compared to 23.5% same period last year
- Net Debt increased by $3.0 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0.0 bln (positive), 7.1% of market cap
- EV/EBITDA multiple is 20.1x compared to historical level (75th percentile) of 73.2x
- EV/Sales multiple is 3.9x

------------------------------------------------

2024-04-09

#reports #XTNT

[Xtant Medical](https://eninvs.com/all.php?name=XTNT) (Medical Devices) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165183)
(2024-04-01, Before Market Open):

- Revenue +86.7% YoY (vs +78.6% in previous quarter and historical rate +22.3%)
- EBITDA margin -10.7% decreased compared to -6.7% same period last year
- Net Debt decreased by $14.0 mln over the past reporting period (12.4% of market cap)
- FCF (LTM) -$0.0 bln (negative), 2.7% of market cap
- EV/Sales multiple is 1.2x

The company showed EPS -$0.03 per share. At the opening of the session the share price went up +0.9% vs S&P500 +0.1%

------------------------------------------------

2024-04-09

#reports #VISL

[Vislink Technologies](https://eninvs.com/all.php?name=VISL) (Communication Equipment) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165313)
(2024-04-01, Before Market Open):

- Revenue +14.3% YoY (vs 0.0% in previous quarter and historical rate +13.8%)
- EBITDA margin -25.0% increased compared to -71.4% same period last year
- Net Debt decreased by $1.0 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) -$0.0 bln (negative), 10.5% of market cap
- EV/Sales multiple is 5.8x

The company showed EPS -$0.99 per share. At the opening of the session the share price went up +0.3% vs S&P500 +0.1%

------------------------------------------------

2024-04-09

#reports #TTOO

[T2 Biosystems](https://eninvs.com/all.php?name=TTOO) (Diagnostics and Research) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165272)
(2023-03-01, After Market Close):

- Revenue 0.0% YoY (vs -33.3% in previous quarter and historical rate +9.6%)
- EBITDA margin -300.0% increased compared to -666.7% same period last year
- Net Debt increased by $8.0 mln over the past reporting period (3.5% of market cap)
- FCF (LTM) +$0.0 bln (positive), 4.4% of market cap
- EV/Sales multiple is 16.8x

The company showed EPS -$2.55 per share. At the opening of the session the share price went up +0.8% vs S&P500 -0.4%

------------------------------------------------

2024-04-09

#reports #TCX

[Tucows](https://eninvs.com/all.php?name=TCX) (Domain name registrar) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165223)
(2024-02-22, After Market Close):

- Revenue +10.1% YoY (vs +11.5% in previous quarter and historical rate +3.4%)
- EBITDA margin -6.9% decreased compared to -6.3% same period last year
- Net Debt decreased by $89.0 mln over the past reporting period (46.4% of market cap)
- FCF (LTM) +$0.2 bln (positive), 79.8% of market cap
- EV/Sales multiple is 0.4x

The company showed EPS -$2.14 per share. At the opening of the session the share price went up +2.6% vs S&P500 +0.3%

------------------------------------------------

2024-04-09

#reports #SYPR

[Sypris Solutions](https://eninvs.com/all.php?name=SYPR) (Auto Parts) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165214)
(2024-03-29, Before Market Open):

- Revenue +16.7% YoY (vs +36.0% in previous quarter and historical rate +19.8%)
- EBITDA -50.0% YoY (vs 0.0% in previous quarter)
- EBITDA margin 2.9% decreased compared to 6.7% same period last year
- Net Debt increased by $3.0 mln over the past reporting period (8.0% of market cap)
- FCF (LTM) -$0.0 bln (negative), 34.8% of market cap
- EV/EBITDA multiple is 8.6x compared to historical level (75th percentile) of 15.0x
- EV/Sales multiple is 0.3x

The company showed EPS -$0.05 per share

------------------------------------------------

2024-04-09

#reports #SPWH

[Sportsmans](https://eninvs.com/all.php?name=SPWH) (Specialty Retail) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165315)
(2024-04-03, After Market Close):

- Revenue -2.4% YoY (vs -5.3% in previous quarter and historical rate -2.8%)
- EBITDA -88.0% YoY (vs -46.2% in previous quarter and historical rate -41.9%)
- EBITDA margin 0.8% decreased compared to 6.6% same period last year
- Net Debt decreased by $51.0 mln over the past reporting period (36.9% of market cap)
- FCF (LTM) -$0.1 bln (negative), 63.6% of market cap
- EV/EBITDA multiple is 43.3x compared to historical level (75th percentile) of 14.3x
- EV/Sales multiple is 0.5x

The company showed EPS -$0.23 per share. At the opening of the session the share price went up +2.2% vs S&P500 +0.6%

------------------------------------------------

2024-04-09

#reports #SGRP

[SPAR Group](https://eninvs.com/all.php?name=SGRP) (Specialty Business Services) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165178)
(2024-04-01, Before Market Open):

- Revenue 0.0% YoY (vs -4.3% in previous quarter and historical rate +4.9%)
- Net Income margin 4.6% increased compared to -1.5% same period last year
- P/E multiple is 3.7x compared to historical level (75th percentile) of 6.5x
- P/S multiple is 0.2x
- Price to book: 1.5x

The company showed EPS +$0.09 per share. At the opening of the session the share price went up +21.7% vs S&P500 +0.1%

------------------------------------------------

2024-04-09

#reports #RHE

[Regional Health Properties](https://eninvs.com/all.php?name=RHE) (Medical Care Facilities) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165255)
(2024-04-08, Before Market Open):

- Revenue -50.0% YoY (vs -63.6% in previous quarter and historical rate +9.4%)
- EBITDA margin 20.0% increased compared to -20.0% same period last year
- Net Debt increased by $1.0 mln over the past reporting period (20782.8% of market cap)
- FCF (LTM) +$0.0 bln (positive), 914441.5% of market cap
- EV/EBITDA multiple is 13.0x compared to historical level (75th percentile) of 26.5x
- EV/Sales multiple is 1.4x

The company showed EPS -$0.13 per share. At the opening of the session the share price went up +1.8% vs S&P500 +0.1%

------------------------------------------------

2024-04-09

#reports #POLA

[Polar Power](https://eninvs.com/all.php?name=POLA) (Electrical Equipment and Parts) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165258)
(2024-02-28, After Market Close):

- Revenue -33.3% YoY (vs 0.0% in previous quarter and historical rate +31.1%)
- EBITDA margin -75.0% decreased compared to -16.7% same period last year
- Net Debt decreased by $1.0 mln over the past reporting period (16.3% of market cap)
- FCF (LTM) -$0.0 bln (negative), 81.4% of market cap
- EV/Sales multiple is 0.8x

The company showed EPS -$0.24 per share. At the opening of the session the share price went down -0.1% vs S&P500 +0.4%

------------------------------------------------

2024-04-09

#reports #PDS

[Precision Drilling Corporation](https://eninvs.com/all.php?name=PDS) (Oil and Gas Drilling) reported for [2023 q4](https://eninvs.com/press_release.php?ticker=PDS&q=2023 q4&id=723137)
(2024-02-06, Before Market Open):

- Revenue -0.8% YoY (vs +4.2% in previous quarter and historical rate +51.5%)
- EBITDA +42.0% YoY (vs -0.5% in previous quarter and historical rate +61.0%)
- EBITDA margin 45.4% increased compared to 31.7% same period last year
- EV/EBITDA multiple is 1.1x compared to historical level (75th percentile) of 8.7x
- EV/Sales multiple is 0.5x

The company showed EPS +$9.81 per share. At the opening of the session the share price went up +10.2% vs S&P500 0.0%

------------------------------------------------

2024-04-09

#reports #OXM

[Oxford Industries](https://eninvs.com/all.php?name=OXM) (Clothes manufacturer) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165231)
(2024-03-28, After Market Close):

- Revenue +5.8% YoY (vs +4.5% in previous quarter and historical rate +29.7%)
- EBITDA -162.0% YoY (vs -36.1% in previous quarter and historical rate +59.5%)
- EBITDA margin -7.7% decreased compared to 13.1% same period last year
- EV/EBITDA multiple is 12.2x compared to historical level (75th percentile) of 10.0x
- EV/Sales multiple is 1.3x

The company showed EPS -$3.85 per share

------------------------------------------------

2024-04-09

#reports #OVLY

[Oak Valley Bancorp](https://eninvs.com/all.php?name=OVLY) (Banks — Regional) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165240)
(2024-01-22, Before Market Open):

- Revenue -15.0% YoY (vs +11.8% in previous quarter and historical rate +16.8%)
- Net Income -33.3% YoY (vs +11.1% in previous quarter and historical rate +52.9%)
- Net Income margin 47.1% decreased compared to 60.0% same period last year
- P/E multiple is 4.6x compared to historical level (75th percentile) of 8.3x
- P/S multiple is 2.5x
- Price to book: 1.1x

The company showed EPS +$0.71 per share. At the opening of the session the share price went down -2.0% vs S&P500 +0.4%

------------------------------------------------

2024-04-09

#reports #NGS

[Natural Gas Services Group](https://eninvs.com/all.php?name=NGS) (Oil and Gas Equipment and Services) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165173)
(2024-04-01, After Market Close):

- Revenue +50.0% YoY (vs +47.6% in previous quarter and historical rate +20.8%)
- EBITDA +71.4% YoY (vs +140.0% in previous quarter and historical rate +25.0%)
- EBITDA margin 33.3% increased compared to 29.2% same period last year
- Net Debt increased by $44.0 mln over the past reporting period (15.2% of market cap)
- FCF (LTM) -$0.1 bln (negative), 48.1% of market cap
- EV/EBITDA multiple is 11.8x compared to historical level (75th percentile) of 8.4x
- EV/Sales multiple is 3.7x

The company showed EPS +$0.14 per share. At the opening of the session the share price went up +1.2% vs S&P500 -0.8%

------------------------------------------------

2024-04-09

#reports #NEOG

[Neogen](https://eninvs.com/all.php?name=NEOG) (Food testing equipment manufacturer) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=NEOG&q=2024 q1&id=684465)
(2024-04-09, Before Market Open):

- Revenue +5.0% YoY (vs 0.0% in previous quarter and historical rate +30.7%)
- EBITDA -22.7% YoY (vs -2200.0% in previous quarter and historical rate -0.4%)
- EBITDA margin 7.4% decreased compared to 10.1% same period last year
- Net Debt increased by $55.0 mln over the past reporting period (1.8% of market cap)
- FCF (LTM) +$0.0 bln (positive), 1.1% of market cap
- EV/EBITDA multiple is 76.6x compared to historical level (75th percentile) of 76.1x
- EV/Sales multiple is 4.1x

At the opening of the session the share price went down -7.6% vs S&P500 +0.3%

------------------------------------------------

2024-04-09

#reports #MYSZ

[My Size](https://eninvs.com/all.php?name=MYSZ) (Software — Application) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165237)
(2022-11-17):

- Revenue 0.0% YoY (vs +100.0% in previous quarter and historical rate +75.0%)
- EBITDA margin -66.7% has not changed compared to -66.7% same period last year
- Net Debt increased by $3.0 mln over the past reporting period (240.0% of market cap)
- FCF (LTM) -$0.0 bln (negative), 320.0% of market cap
- EV/EBITDA multiple is 0.3x compared to historical level (75th percentile) of 0.3x
- EV/Sales multiple is -0.3x

The company showed EPS -$0.38 per share

------------------------------------------------

2024-04-09

#reports #CLRO

[ClearOne](https://eninvs.com/all.php?name=CLRO) (Communication Equipment) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165217)
(2024-04-02, Before Market Open):

- Revenue 0.0% YoY (vs -16.7% in previous quarter and historical rate -11.3%)
- EBITDA margin -50.0% has not changed compared to -50.0% same period last year
- Net Debt decreased by $4.0 mln over the past reporting period (10.6% of market cap)
- FCF (LTM) +$0.0 bln (positive), 63.4% of market cap
- EV/Sales multiple is 0.9x

The company showed EPS +$0.11 per share. At the opening of the session the share price went down -0.5% vs S&P500 -0.8%

------------------------------------------------

2024-04-09

#reports #AWH

[Aspira Women's Health](https://eninvs.com/all.php?name=AWH) (Treatments for gynecological problems developer ) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165220)
(2023-08-14, Before Market Open):

- Revenue 0.0% YoY (vs 0.0% in previous quarter and historical rate +33.3%)
- EBITDA margin -150.0% increased compared to -300.0% same period last year
- Net Debt increased by $2.0 mln over the past reporting period (7.7% of market cap)
- FCF (LTM) -$0.0 bln (negative), 23.0% of market cap
- EV/Sales multiple is 3.5x

The company showed EPS -$0.30 per share. At the opening of the session the share price went up +0.6% vs S&P500 -0.1%

------------------------------------------------

2024-04-09

#reports #ACOR

[Acorda Therapeutics](https://eninvs.com/all.php?name=ACOR) (Drug Manufacturers — Specialty and Generic) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165159)
(2023-08-08, After Market Close):

- Revenue +22.6% YoY (vs -17.6% in previous quarter and historical rate -6.6%)
- EBITDA margin -634.2% decreased compared to -22.6% same period last year
- Net Debt increased by $7.0 mln over the past reporting period (24.0% of market cap)
- FCF (LTM) -$0.0 bln (negative), 85.6% of market cap
- EV/Sales multiple is 1.6x

The company showed EPS -$225.81 per share. At the opening of the session the share price went down -2.2% vs S&P500 0.0%

------------------------------------------------

2024-04-09

#reports #IHT
@ REITs

[InnSuites Hospitality Trust](https://eninvs.com/all.php?name=IHT) (REIT — Hotel and Motel) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165356)
(2023-12-25, After Market Close):

- Revenue 0.0% YoY (vs 0.0% in previous quarter and historical rate +15.3%)
- EBITDA margin -50.0% decreased compared to 0.0% same period last year
- EV/EBITDA multiple is 20.7x compared to historical level (75th percentile) of 34.0x
- EV/Sales multiple is 2.5x

At the opening of the session the share price went up +2.8% vs S&P500 +0.1%

------------------------------------------------

2024-04-09

#reports #PRGS

[Progress Software](https://eninvs.com/all.php?name=PRGS) (Software provider) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165354)
(2024-03-26, After Market Close):

- Revenue +12.8% YoY (vs +12.7% in previous quarter and historical rate +16.8%)
- EBITDA +8.8% YoY (vs -26.5% in previous quarter and historical rate +12.5%)
- EBITDA margin 33.5% decreased compared to 34.8% same period last year
- Net Debt decreased by $41.0 mln over the past reporting period (1.9% of market cap)
- FCF (LTM) +$0.2 bln (positive), 7.6% of market cap
- EV/EBITDA multiple is 13.6x compared to historical level (75th percentile) of 15.0x
- EV/Sales multiple is 3.9x

The company showed EPS +$0.51 per share. At the opening of the session the share price went up +0.1% vs S&P500 +0.4%

------------------------------------------------

2024-04-06

#reports #JBL

[Jabil](https://eninvs.com/all.php?name=JBL) (Electronics manufacturer) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165342)
(2024-03-15, Before Market Open):

- Revenue -16.8% YoY (vs -29.8% in previous quarter and historical rate +3.5%)
- EBITDA +110.0% YoY (vs +110.4% in previous quarter and historical rate +57.5%)
- EBITDA margin 18.9% increased compared to 7.5% same period last year
- Net Debt decreased by $4555.3 bln over the past reporting period (23575.1% of market cap)
- FCF (LTM) -$4553.0 bln (negative), 23563.6% of market cap
- EV/EBITDA multiple is 1196.9x compared to historical level (75th percentile) of 7.7x
- EV/Sales multiple is 150.1x

The company showed EPS +$7.30 per share. At the opening of the session the share price went down -12.7% vs S&P500 -0.5%

------------------------------------------------

2024-04-06

#reports #CTAS

[Cintas](https://eninvs.com/all.php?name=CTAS) ( Identity uniform manufacturer) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165343)
(2024-03-27, Before Market Open):

- Revenue +9.9% YoY (vs +9.3% in previous quarter and historical rate +26.7%)
- Net Income +22.1% YoY (vs +15.7% in previous quarter and historical rate +11.1%)
- Net Income margin 16.5% increased compared to 14.9% same period last year
- P/E multiple is 31.4x compared to historical level (75th percentile) of 27.7x
- P/S multiple is 5.0x
- Price to book: 16.2x

The company showed EPS +$3.85 per share. At the opening of the session the share price went up +4.0% vs S&P500 +0.4%

------------------------------------------------

2024-04-05

#reports #KRUS

[Kura Sushi USA](https://eninvs.com/all.php?name=KRUS) (Restaurants) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165320)
(2024-04-04, After Market Close):

- Revenue +147.7% YoY (vs +30.8% in previous quarter and historical rate +106.0%)
- EBITDA margin -1.8% increased compared to -2.3% same period last year
- Net Debt increased by $13.0 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) -$0.1 bln (negative), 7.4% of market cap
- EV/EBITDA multiple is 630.1x compared to historical level (75th percentile) of 683.0x
- EV/Sales multiple is 4.8x

------------------------------------------------

2024-04-04

#reports #LNN

[Lindsay Corporation](https://eninvs.com/all.php?name=LNN) (Irrigation, infrastructure products manufacturer) reported for 2024 q1
(2024-04-04, Before Market Open):

- Revenue -8.4% YoY (vs -8.5% in previous quarter and historical rate +11.4%)
- EBITDA -15.6% YoY (vs -10.3% in previous quarter and historical rate +35.1%)
- EBITDA margin 17.8% decreased compared to 19.3% same period last year
- Net Debt increased by $25.0 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) +$0.0 bln (positive), 0.8% of market cap
- EV/EBITDA multiple is 10.8x compared to historical level (75th percentile) of 22.1x
- EV/Sales multiple is 1.9x

At the opening of the session the share price went up +1.9% vs S&P500 +0.6%

------------------------------------------------

2024-04-04

#reports #CAG

[Conagra Brands](https://eninvs.com/all.php?name=CAG) (Food products provider) reported for 2024 q1
(2024-04-04, Before Market Open):

- Revenue -1.7% YoY (vs -3.2% in previous quarter and historical rate +1.4%)
- EBITDA -3.8% YoY (vs -81.2% in previous quarter and historical rate -5.7%)
- EBITDA margin 24.5% decreased compared to 25.0% same period last year
- Net Debt decreased by $479.0 mln over the past reporting period (3.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.8% of market cap
- EV/EBITDA multiple is 16.1x compared to historical level (75th percentile) of 15.5x
- EV/Sales multiple is 1.9x

At the opening of the session the share price went up +4.7% vs S&P500 +0.6%

------------------------------------------------

2024-04-04

#reports #LEVI

[Levi Strauss &](https://eninvs.com/all.php?name=LEVI) (Clothes manufacturer) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=LEVI&q=2024 q1&id=764229)
(2024-04-03, After Market Close):

- Revenue -7.8% YoY (vs +3.3% in previous quarter and historical rate +20.3%)
- EBITDA -77.7% YoY (vs +365.2% in previous quarter and historical rate +41.7%)
- EBITDA margin 2.8% decreased compared to 11.7% same period last year
- Net Debt decreased by $136.0 mln over the past reporting period (1.8% of market cap)
- FCF (LTM) +$0.2 bln (positive), 3.0% of market cap
- EV/EBITDA multiple is 9.1x compared to historical level (75th percentile) of 15.8x
- EV/Sales multiple is 1.5x

------------------------------------------------

2024-04-04

#reports #BB

[BlackBerry Limited](https://eninvs.com/all.php?name=BB) (Software — Infrastructure) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=BB&q=2024 q1&id=764234)
(2024-04-03, After Market Close):

- Revenue +14.6% YoY (vs +3.6% in previous quarter and historical rate +1.9%)
- EBITDA margin 1.7% increased compared to -260.9% same period last year
- EV/Sales multiple is 1.8x

------------------------------------------------

2024-04-02

#reports #PAYX

[Paychex](https://eninvs.com/all.php?name=PAYX) (Financial services provider) reported for 2024 q1
(2024-04-02, Before Market Open):

- Revenue +4.2% YoY (vs +5.7% in previous quarter and historical rate +9.9%)
- EBITDA +6.1% YoY (vs +6.7% in previous quarter and historical rate +17.5%)
- EBITDA margin 52.3% increased compared to 51.4% same period last year
- Net Debt decreased by $327.0 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.1% of market cap
- EV/EBITDA multiple is 17.0x compared to historical level (75th percentile) of 23.4x
- EV/Sales multiple is 8.3x

The company showed EPS +$1.38 per share. At the opening of the session the share price went up +0.4% vs S&P500 -0.8%

------------------------------------------------

2024-03-30

#reports #PRPO

[Precipio](https://eninvs.com/all.php?name=PRPO) (Diagnostics and Research) reported for 2023 q4
(2023-11-13, After Market Close):

- Revenue +33.3% YoY (vs +150.0% in previous quarter and historical rate +56.9%)
- EBITDA margin -125.0% increased compared to -133.3% same period last year
- EV/Sales multiple is 10.2x

At the opening of the session the share price went down -7.1% vs S&P500 +1.0%

------------------------------------------------

2024-03-30

#reports #IRIX

[IRIDEX Corporation](https://eninvs.com/all.php?name=IRIX) (Medical Devices) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165092)
(2024-03-26, After Market Close):

- Revenue -20.0% YoY (vs -13.3% in previous quarter and historical rate +28.8%)
- EBITDA margin -16.7% decreased compared to -6.7% same period last year
- Net Debt increased by $3.0 mln over the past reporting period (6.2% of market cap)
- FCF (LTM) -$0.0 bln (negative), 16.5% of market cap
- EV/Sales multiple is 0.9x

At the opening of the session the share price went up +7.6% vs S&P500 +0.4%

------------------------------------------------

2024-03-30

#reports #ESCA

[Escalade](https://eninvs.com/all.php?name=ESCA) (Leisure) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165077)
(2024-04-01, Before Market Open):

- Revenue -8.3% YoY (vs -2.7% in previous quarter and historical rate +2.3%)
- EBITDA +300.0% YoY (vs +40.0% in previous quarter and historical rate +11.2%)
- EBITDA margin 12.1% increased compared to 2.8% same period last year
- EV/EBITDA multiple is 7.8x compared to historical level (75th percentile) of 11.2x
- EV/Sales multiple is 0.7x

The company showed EPS +$0.71 per share

------------------------------------------------

2024-03-30

#reports #AXDX

[Accelerate Diagnostics](https://eninvs.com/all.php?name=AXDX) (Diagnostics and Research) reported for [2023 q4](https://eninvs.com/press_release.php?ticker=AXDX&q=2023 q4&id=763961)
(2024-03-28, After Market Close):

- Revenue 0.0% YoY (vs 0.0% in previous quarter and historical rate +6.9%)
- EBITDA margin -333.3% increased compared to -433.3% same period last year
- Net Debt increased by $2.0 mln over the past reporting period (2.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 99.7% of market cap
- EV/Sales multiple is 11.8x

The company showed EPS -$1.49 per share

------------------------------------------------

2024-03-29

#reports #ENSV

[Enservco Corporation](https://eninvs.com/all.php?name=ENSV) (Oil and Gas Equipment and Services) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165051)
(2024-03-28, Before Market Open):

- Revenue -14.3% YoY (vs 0.0% in previous quarter and historical rate +27.5%)
- EBITDA margin -16.7% decreased compared to -14.3% same period last year
- Net Debt increased by $2.0 mln over the past reporting period (44.8% of market cap)
- FCF (LTM) +$0.0 bln (positive), 358.7% of market cap
- EV/Sales multiple is 0.5x

At the opening of the session the share price went up +1.9% vs S&P500 0.0%

------------------------------------------------

2024-03-29

#reports #CMCT

[CIM Commercial Trust Corporation](https://eninvs.com/all.php?name=CMCT) (REIT — Office) reported for [2023 q4](https://eninvs.com/press_release.php?ticker=CMCT&q=2023 q4&id=763902)
(2024-03-27, After Market Close):

- Revenue +11.5% YoY (vs +12.0% in previous quarter and historical rate +17.3%)
- EBITDA +122.2% YoY (vs +1000.0% in previous quarter and historical rate +89.7%)
- EBITDA margin 69.0% increased compared to 34.6% same period last year
- EV/EBITDA multiple is 18.5x compared to historical level (75th percentile) of 58.4x
- EV/Sales multiple is 15.8x

At the opening of the session the share price went down -1.4% vs S&P500 0.0%

------------------------------------------------

2024-03-29

#reports #WBA

[Walgreens Boots Alliance](https://eninvs.com/all.php?name=WBA) (Network of retail pharmacies) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=164970)
(2024-03-28, Before Market Open):

- Revenue +6.3% YoY (vs +11.0% in previous quarter and historical rate +1.7%)
- EBITDA -1758.8% YoY (vs -1254700.0% in previous quarter and historical rate -44.9%)
- EBITDA margin -33.9% decreased compared to 2.2% same period last year
- Net Debt increased by $1.7 bln over the past reporting period (9.1% of market cap)
- FCF (LTM) +$9.3 bln (positive), 49.7% of market cap
- EV/Sales multiple is 0.4x

The company showed EPS -$14.14 per share. At the opening of the session the share price went down -2.0% vs S&P500 0.0%

------------------------------------------------

2024-03-29

#reports #STRS

[Stratus Properties](https://eninvs.com/all.php?name=STRS) (Real Estate — Diversified) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165013)
(2024-03-25, Before Market Open):

- Revenue -69.2% YoY (vs -60.0% in previous quarter and historical rate -8.6%)
- EBITDA margin -25.0% increased compared to -46.2% same period last year
- EV/Sales multiple is 22.3x

At the opening of the session the share price went up +1.6% vs S&P500 -0.3%

------------------------------------------------

2024-03-29

#reports #SMTC

[Semtech](https://eninvs.com/all.php?name=SMTC) (Semiconductor manufacturer) reported for [2023 q4](https://eninvs.com/press_release.php?ticker=SMTC&q=2023 q4&id=763972)
(2024-03-28, After Market Close):

- Revenue +14.9% YoY (vs +12.9% in previous quarter and historical rate +14.1%)
- EBITDA margin -320.2% decreased compared to -24.4% same period last year
- Net Debt decreased by $7.0 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 7.8% of market cap
- EV/Sales multiple is 3.5x

The company showed EPS -$9.98 per share

------------------------------------------------

2024-03-29

#reports #RKDA

[Arcadia Biosciences](https://eninvs.com/all.php?name=RKDA) (Agricultural Inputs) reported for [2023 q4](https://eninvs.com/press_release.php?ticker=RKDA&q=2023 q4&id=763971)
(2024-03-28, After Market Close):

- Revenue 0.0% YoY (vs 0.0% in previous quarter and historical rate +64.2%)
- EBITDA margin -300.0% increased compared to -600.0% same period last year
- Net Debt increased by $4.0 mln over the past reporting period (302.0% of market cap)
- FCF (LTM) -$0.0 bln (negative), 452.9% of market cap
- EV/EBITDA multiple is 0.7x compared to historical level (75th percentile) of 0.9x
- EV/Sales multiple is -1.6x

On post-market the stock shows a growth by +3.2%

------------------------------------------------

2024-03-29

#reports #POAI

[Predictive Oncology](https://eninvs.com/all.php?name=POAI) (Medical Instruments and Supplies) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165044)
(2023-05-17, After Market Close):

- Revenue -7.7% YoY (vs +56.8% in previous quarter and historical rate +73.4%)
- EBITDA margin -991.3% increased compared to -2195.9% same period last year
- Net Debt increased by $3.0 bln over the past reporting period (1631.5% of market cap)
- FCF (LTM) -$13.8 bln (negative), 7423.3% of market cap
- EV/EBITDA multiple is 0.8x compared to historical level (75th percentile) of 1.5x
- EV/Sales multiple is -4.4x

------------------------------------------------

2024-03-29

#reports #PMD

[Psychemedics Corporation](https://eninvs.com/all.php?name=PMD) (Diagnostics and Research) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165010)
(2024-03-25, After Market Close):

- Revenue -16.7% YoY (vs -14.3% in previous quarter and historical rate +9.1%)
- EBITDA margin -20.0% decreased compared to 16.7% same period last year
- EV/Sales multiple is 0.8x

At the opening of the session the share price went up +0.7% vs S&P500 +0.2%

------------------------------------------------

2024-03-29

#reports #MTEX

[Mannatech](https://eninvs.com/all.php?name=MTEX) (Household and Personal Products) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165028)
(2024-03-25, Before Market Open):

- Revenue -2.9% YoY (vs -8.3% in previous quarter and historical rate +1.3%)
- EBITDA -20.0% YoY (vs 0.0% in previous quarter)
- EBITDA margin 12.1% decreased compared to 14.7% same period last year
- EV/EBITDA multiple is 2.0x compared to historical level (75th percentile) of 2.9x
- EV/Sales multiple is 0.1x

------------------------------------------------

2024-03-29

#reports #GRNQ

[Greenpro Capital](https://eninvs.com/all.php?name=GRNQ) (Consulting Services) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165039)
(2022-05-10):

- Revenue 0.0% YoY (vs 0.0% in previous quarter and historical rate +50.0%)
- EBITDA margin -100.0% decreased compared to 0.0% same period last year
- Net Debt decreased by $2.0 mln over the past reporting period (18.9% of market cap)
- EV/Sales multiple is 2.1x

------------------------------------------------

2024-03-29

#reports #FEMY

[Femasys Inc.](https://eninvs.com/all.php?name=FEMY) (Medical Instruments and Supplies) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=164983)
(2024-03-28, Before Market Open):

- Revenue -11.1% YoY (vs -29.7% in previous quarter and historical rate +73.0%)
- EBITDA margin -1308.3% decreased compared to -270.8% same period last year
- Net Debt decreased by $9.2 bln over the past reporting period (50160.9% of market cap)
- FCF (LTM) +$2.6 bln (positive), 14182.7% of market cap
- EV/EBITDA multiple is 0.6x compared to historical level (75th percentile) of 1.4x
- EV/Sales multiple is -7.8x

At the opening of the session the share price went down -2.0% vs S&P500 0.0%

------------------------------------------------

2024-03-29

#reports #FBIOP

[Fortress Biotech](https://eninvs.com/all.php?name=FBIOP) (Biotechnology) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=165042):

- Revenue +25.0% YoY (vs +105.9% in previous quarter and historical rate +33.8%)
- EBITDA margin -500.0% has not changed compared to -500.0% same period last year
- Net Debt increased by $11.0 mln over the past reporting period (8.8% of market cap)
- FCF (LTM) -$0.0 bln (negative), 16.1% of market cap
- EV/Sales multiple is 1.3x

------------------------------------------------

2024-03-29

#reports #CURV

[Torrid Holdings Inc.](https://eninvs.com/all.php?name=CURV) (Apparel Retail) reported for [2023 q4](https://eninvs.com/press_release.php?ticker=CURV&q=2023 q4&id=763965)
(2024-03-28, After Market Close):

- Revenue -2.3% YoY (vs -5.2% in previous quarter and historical rate -7.5%)
- EBITDA +16.7% YoY (vs -44.8% in previous quarter and historical rate -29.4%)
- EBITDA margin 4.8% increased compared to 4.0% same period last year
- Net Debt decreased by $3.0 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.0 bln (positive), 6.7% of market cap
- EV/EBITDA multiple is 10.5x compared to historical level (75th percentile) of 9.6x
- EV/Sales multiple is 0.9x

------------------------------------------------

2024-03-28

#reports #WBA

[Walgreens Boots Alliance](https://eninvs.com/all.php?name=WBA) (Network of retail pharmacies) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=161129)
(2024-01-04, Before Market Open):

- Revenue +11.0% YoY (vs +9.2% in previous quarter and historical rate +0.5%)
- EBITDA margin -33.9% decreased compared to -16.9% same period last year
- Net Debt increased by $166.0 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) -$1.5 bln (negative), 8.4% of market cap
- EV/Sales multiple is 0.4x

The company showed EPS -$0.08 per share vs analyst consensus of +$0.95. At the opening of the session the share price went down -5.4% vs S&P500 -0.2%

------------------------------------------------

2024-03-28

#reports #JFIN

[Jiayin Group](https://eninvs.com/all.php?name=JFIN) (Internet Content and Information) reported for 2023 q4
(2024-03-28, Before Market Open):

- Revenue +47.1% YoY (vs +59.5% in previous quarter and historical rate +67.1%)
- EBITDA -22.9% YoY (vs +10.4% in previous quarter and historical rate +88.0%)
- EBITDA margin 24.0% decreased compared to 45.8% same period last year
- EV/EBITDA multiple is 1.3x compared to historical level (75th percentile) of 1.4x
- EV/Sales multiple is 0.4x

At the opening of the session the share price went down -3.9% vs S&P500 0.0%

------------------------------------------------

2024-03-28

#reports #DRIO

[DarioHealth](https://eninvs.com/all.php?name=DRIO) (Diagnostics and Research) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=164962)
(2024-03-28, Before Market Open):

- Revenue -42.9% YoY (vs -42.9% in previous quarter and historical rate +49.3%)
- EBITDA +55.6% YoY (vs +6.7% in previous quarter and historical rate +88.5%)
- EBITDA margin 350.0% increased compared to 128.6% same period last year
- Net Debt decreased by $26.0 mln over the past reporting period (74.8% of market cap)
- FCF (LTM) -$0.0 bln (negative), 74.8% of market cap
- EV/Sales multiple is -0.7x

At the opening of the session the share price went up +1.3% vs S&P500 0.0%

------------------------------------------------

2024-03-28

#reports #CAAS

[China Automotive Systems](https://eninvs.com/all.php?name=CAAS) (Auto Parts) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=164963)
(2024-03-28, Before Market Open):

- Revenue +23.3% YoY (vs +0.7% in previous quarter and historical rate +31.8%)
- EBITDA +280.0% YoY (vs +40.0% in previous quarter and historical rate +80.2%)
- EBITDA margin 11.9% increased compared to 3.9% same period last year
- Net Debt decreased by $47.0 mln over the past reporting period (46.2% of market cap)
- FCF (LTM) -$0.0 bln (negative), 37.4% of market cap
- EV/Sales multiple is -0.0x

At the opening of the session the share price went up +5.9% vs S&P500 0.0%

------------------------------------------------

2024-03-28

#reports #VRNT

[Verint Systems](https://eninvs.com/all.php?name=VRNT) (Software developer) reported for 2023 q4
(2024-03-27, After Market Close):

- Revenue +12.3% YoY (vs -2.7% in previous quarter and historical rate -9.0%)
- EBITDA -14.3% YoY (vs +105.1% in previous quarter and historical rate -27.5%)
- EBITDA margin 15.8% decreased compared to 20.8% same period last year
- Net Debt decreased by $671.0 mln over the past reporting period (34.4% of market cap)
- FCF (LTM) +$0.9 bln (positive), 45.0% of market cap
- EV/EBITDA multiple is 20.6x compared to historical level (75th percentile) of 28.9x
- EV/Sales multiple is 2.9x

------------------------------------------------

2024-03-28

#reports #TKNO

[Alpha Teknova, Inc.](https://eninvs.com/all.php?name=TKNO) (Drug Manufacturers — Specialty and Generic) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=164930)
(2024-03-11, After Market Close):

- Revenue 0.0% YoY (vs -27.3% in previous quarter and historical rate +3.6%)
- EBITDA margin -300.0% decreased compared to -162.5% same period last year
- Net Debt increased by $3.0 mln over the past reporting period (4.3% of market cap)
- FCF (LTM) +$0.0 bln (positive), 13.0% of market cap
- EV/Sales multiple is 1.9x

The company showed EPS -$0.26 per share. At the opening of the session the share price went down -5.3% vs S&P500 +0.3%

------------------------------------------------

2024-03-28

#reports #QUIK

[QuickLogic Corporation](https://eninvs.com/all.php?name=QUIK) (Semiconductors) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=164943)
(2024-02-27, After Market Close):

- Revenue +75.0% YoY (vs +133.3% in previous quarter and historical rate +33.7%)
- EBITDA margin 28.6% increased compared to -25.0% same period last year
- Net Debt increased by $4.0 mln over the past reporting period (1.8% of market cap)
- FCF (LTM) +$0.0 bln (positive), 0.5% of market cap
- EV/Sales multiple is 10.2x

The company showed EPS +$0.15 per share. At the opening of the session the share price went up +16.8% vs S&P500 -0.2%

------------------------------------------------

2024-03-28

#reports #INTT

[inTEST Corporation](https://eninvs.com/all.php?name=INTT) (Semiconductor Equipment and Materials) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=164926)
(2024-03-27, Before Market Open):

- Revenue -12.5% YoY (vs +6.5% in previous quarter and historical rate +36.2%)
- EBITDA -60.0% YoY (vs 0.0% in previous quarter)
- EBITDA margin 7.1% decreased compared to 15.6% same period last year
- Net Debt decreased by $4.0 mln over the past reporting period (2.9% of market cap)
- FCF (LTM) +$0.0 bln (positive), 24.3% of market cap
- EV/EBITDA multiple is 6.3x compared to historical level (75th percentile) of 14.4x
- EV/Sales multiple is 0.8x

At the opening of the session the share price went up +0.9% vs S&P500 +0.4%

------------------------------------------------

2024-03-28

#reports #CXM

[Sprinklr, Inc.](https://eninvs.com/all.php?name=CXM) (Software — Application) reported for [2023 q4](https://eninvs.com/press_release.php?ticker=CXM&q=2023 q4&id=763874)
(2024-03-27, After Market Close):

- Revenue +17.6% YoY (vs +18.5% in previous quarter and historical rate +22.0%)
- EBITDA +1000.0% YoY (vs +1600.0% in previous quarter)
- EBITDA margin 11.3% increased compared to 1.2% same period last year
- Net Debt decreased by $2.0 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 2.0% of market cap
- EV/EBITDA multiple is 66.6x compared to historical level (75th percentile) of 1010.0x
- EV/Sales multiple is 3.7x

------------------------------------------------

2024-03-28

#reports #BRZE

[Braze, Inc.](https://eninvs.com/all.php?name=BRZE) (Software — Application) reported for [2023 q4](https://eninvs.com/press_release.php?ticker=BRZE&q=2023 q4&id=763872)
(2024-03-27, After Market Close):

- Revenue +32.3% YoY (vs +33.3% in previous quarter and historical rate +36.4%)
- EBITDA margin -16.8% increased compared to -28.3% same period last year
- Net Debt decreased by $9.0 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) -$0.0 bln (negative), 0.9% of market cap
- EV/Sales multiple is 9.3x

The company showed EPS -$0.29 per share

------------------------------------------------

2024-03-27

#reports #LE

[Lands' End](https://eninvs.com/all.php?name=LE) (Specialty Retail) reported for 2023 q4
(2024-03-27, Before Market Open):

- Revenue -2.8% YoY (vs -12.4% in previous quarter and historical rate +3.1%)
- EBITDA -18.2% YoY (vs -807.7% in previous quarter and historical rate +14.5%)
- EBITDA margin 3.5% decreased compared to 4.2% same period last year
- Net Debt decreased by $78.0 mln over the past reporting period (26.3% of market cap)
- FCF (LTM) -$0.0 bln (negative), 1.3% of market cap
- EV/Sales multiple is 0.4x

At the opening of the session the share price went up +13.3% vs S&P500 +0.4%

------------------------------------------------

2024-03-27

#reports #DTIL

[Precision BioSciences](https://eninvs.com/all.php?name=DTIL) (Biotechnology) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=164916)
(2024-03-12, Before Market Open):

- Revenue -72.0% YoY (vs -7.1% in previous quarter and historical rate +65.8%)
- EBITDA margin -71.4% decreased compared to -40.0% same period last year
- Net Debt increased by $6.0 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 4.6% of market cap
- EV/Sales multiple is 27.6x

At the opening of the session the share price went up +1.1% vs S&P500 +0.3%

------------------------------------------------

2024-03-27

#reports #XYF

[X Financial](https://eninvs.com/all.php?name=XYF) (Credit Services) reported for [2023 q4](https://eninvs.com/press_release.php?ticker=XYF&q=2023 q4&id=763750)
(2024-03-26, Before Market Open):

- Revenue +20.9% YoY (vs +51.6% in previous quarter and historical rate +47.2%)
- Net Income -32.5% YoY (vs +60.0% in previous quarter and historical rate +58.7%)
- Net Income margin 16.1% decreased compared to 28.8% same period last year
- P/E multiple is 1.5x compared to historical level (75th percentile) of 1.4x
- P/S multiple is 0.4x
- Price to book: 0.3x

At the opening of the session the share price went down -0.9% vs S&P500 +0.2%

------------------------------------------------

2024-03-27

#reports #WHLM

[Wilhelmina International](https://eninvs.com/all.php?name=WHLM) (Specialty Business Services) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=164875)
(2024-03-25, After Market Close):

- Revenue 0.0% YoY (vs -75.0% in previous quarter and historical rate +0.6%)
- P/E multiple is 24.8x compared to historical level (75th percentile) of 11.5x
- P/S multiple is 1.5x
- Price to book: 1.0x

At the opening of the session the share price went down -6.9% vs S&P500 +0.2%

------------------------------------------------

2024-03-27

#reports #UNB

[Union Bankshares](https://eninvs.com/all.php?name=UNB) (Banks — Regional) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=164897)
(2024-01-17, After Market Close):

- Revenue -10.0% YoY (vs -10.0% in previous quarter and historical rate -6.6%)
- Net Income margin 66.7% increased compared to -20.0% same period last year
- P/E multiple is 11.6x compared to historical level (75th percentile) of 31.0x
- P/S multiple is 3.6x
- Price to book: 2.1x

The company showed EPS +$2.48 per share. At the opening of the session the share price went down -0.3% vs S&P500 +0.6%

------------------------------------------------

2024-03-27

#reports #NCNO

[nCino](https://eninvs.com/all.php?name=NCNO) (Cloud software provider) reported for [2023 q4](https://eninvs.com/press_release.php?ticker=NCNO&q=2023 q4&id=763739)
(2024-03-26, After Market Close):

- Revenue +13.8% YoY (vs +16.2% in previous quarter and historical rate +33.3%)
- EBITDA margin 5.6% increased compared to -11.0% same period last year
- Net Debt decreased by $2.0 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.0 bln (positive), 0.4% of market cap
- EV/EBITDA multiple is 208.1x compared to historical level (75th percentile) of 203.1x
- EV/Sales multiple is 7.0x

------------------------------------------------

2024-03-27

#reports #INTZ

[Intrusion](https://eninvs.com/all.php?name=INTZ) (Software — Infrastructure) reported for [2023 q4](https://eninvs.com/press_release.php?ticker=INTZ&q=2023 q4&id=763736)
(2024-03-26, After Market Close):

- Revenue 0.0% YoY (vs -50.0% in previous quarter and historical rate -16.7%)
- EBITDA margin -300.0% increased compared to -500.0% same period last year
- Net Debt increased by $1.0 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) -$0.0 bln (negative), 5.3% of market cap
- EV/Sales multiple is 27.1x

------------------------------------------------

2024-03-27

#reports #GME
@ gaming

[GameStop](https://eninvs.com/all.php?name=GME) (Specialty Retail) reported for [2023 q4](https://eninvs.com/press_release.php?ticker=GME&q=2023 q4&id=763735)
(2024-03-26, After Market Close):

- Revenue -19.4% YoY (vs -9.1% in previous quarter and historical rate +9.3%)
- EBITDA +91.7% YoY (vs -9700.0% in previous quarter and historical rate -4.7%)
- EBITDA margin 6.4% increased compared to 2.7% same period last year
- Net Debt decreased by $1.0 mln over the past reporting period (0.0% of market cap)
- FCF (LTM) -$0.2 bln (negative), 3.8% of market cap
- EV/Sales multiple is 0.8x

On post-market the stock shows a decrease by -15.3%

------------------------------------------------

2024-03-26

#reports #MOV

[Movado Group](https://eninvs.com/all.php?name=MOV) (Watch manufacturer) reported for 2023 q4
(2024-03-26, Before Market Open):

- Revenue -7.2% YoY (vs -10.9% in previous quarter and historical rate +17.1%)
- EBITDA -44.8% YoY (vs -43.9% in previous quarter and historical rate +42.2%)
- EBITDA margin 8.9% decreased compared to 14.9% same period last year
- Net Debt decreased by $65.0 mln over the past reporting period (10.8% of market cap)
- FCF (LTM) +$0.2 bln (positive), 30.1% of market cap
- EV/EBITDA multiple is 7.0x compared to historical level (75th percentile) of 7.5x
- EV/Sales multiple is 0.6x

At the opening of the session the share price went up +2.1% vs S&P500 +0.2%

------------------------------------------------

2024-03-26

#reports #ESLT

[Elbit Systems](https://eninvs.com/all.php?name=ESLT) (Aerospace and Defense) reported for [2023 q4](https://eninvs.com/press_release.php?ticker=ESLT&q=2023 q4&id=763692)
(2024-03-26, Before Market Open):

- Revenue +8.0% YoY (vs +11.3% in previous quarter and historical rate +9.0%)
- EBITDA -32.3% YoY (vs +30.7% in previous quarter and historical rate +12.8%)
- EBITDA margin 6.7% decreased compared to 10.7% same period last year
- Net Debt decreased by $237.0 mln over the past reporting period (2.6% of market cap)
- FCF (LTM) -$0.4 bln (negative), 4.8% of market cap
- EV/EBITDA multiple is 19.4x compared to historical level (75th percentile) of 18.5x
- EV/Sales multiple is 1.7x

At the opening of the session the share price went up +0.4% vs S&P500 +0.2%

------------------------------------------------

2024-03-26

#reports #DCTH

[Delcath Systems](https://eninvs.com/all.php?name=DCTH) (Medical Devices) reported for 2023 q4
(2024-03-26, Before Market Open):

- Revenue 0.0% YoY (vs -100.0% in previous quarter and historical rate +45.8%)
- EBITDA margin -1200.0% decreased compared to -900.0% same period last year
- Net Debt increased by $8.0 mln over the past reporting period (9.6% of market cap)
- FCF (LTM) +$0.0 bln (positive), 32.4% of market cap
- EV/Sales multiple is 30.6x

At the opening of the session the share price went down -4.8% vs S&P500 +0.2%

------------------------------------------------

2024-03-26

#reports #GDS
@ china

[GDS](https://eninvs.com/all.php?name=GDS) (Information Technology Services) reported for 2023 q4
(2024-03-26, Before Market Open):

- Revenue +3.2% YoY (vs +3.6% in previous quarter and historical rate +20.3%)
- EBITDA -305.0% YoY (vs +0.8% in previous quarter and historical rate +4.4%)
- EBITDA margin -79.2% decreased compared to 39.8% same period last year
- Net Debt increased by $156.0 mln over the past reporting period (9.3% of market cap)
- FCF (LTM) -$0.4 bln (negative), 26.6% of market cap
- EV/EBITDA multiple is 49.1x compared to historical level (75th percentile) of 22.0x
- EV/Sales multiple is 5.4x

At the opening of the session the share price went down -18.7% vs S&P500 +0.2%

------------------------------------------------

2024-03-26

#reports #DOYU
@ china

[DouYu International](https://eninvs.com/all.php?name=DOYU) ( Entertainment services provider) reported for [2023 q4](https://eninvs.com/press_release.php?ticker=DOYU&q=2023 q4&id=763691)
(2024-03-26, Before Market Open):

- Revenue -25.0% YoY (vs -26.5% in previous quarter and historical rate -17.0%)
- EBITDA margin -5.5% decreased compared to -0.4% same period last year
- Net Debt decreased by $48.0 mln over the past reporting period (19.2% of market cap)
- FCF (LTM) -$0.0 bln (negative), 2.8% of market cap
- EV/EBITDA multiple is 49.2x compared to historical level (75th percentile) of 38.0x
- EV/Sales multiple is -0.5x

At the opening of the session the share price went down -7.9% vs S&P500 +0.2%

------------------------------------------------

2024-03-26

#reports #VNRX

[VolitionRx Limited](https://eninvs.com/all.php?name=VNRX) (Diagnostics and Research) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=164828)
(2024-03-25, After Market Close):

- Revenue +103.3% YoY (vs +400.0% in previous quarter and historical rate +108.6%)
- EBITDA margin -3460.7% increased compared to -6468.3% same period last year
- Net Debt decreased by $8.5 bln over the past reporting period (21228.4% of market cap)
- FCF (LTM) +$9.2 bln (positive), 23188.1% of market cap
- EV/EBITDA multiple is 0.4x compared to historical level (75th percentile) of 0.5x
- EV/Sales multiple is -20.1x

------------------------------------------------

2024-03-26

#reports #REKR

[Rekor Systems](https://eninvs.com/all.php?name=REKR) (Software — Infrastructure) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=164826)
(2024-03-25, After Market Close):

- Revenue +120.0% YoY (vs +28.6% in previous quarter and historical rate +58.9%)
- EBITDA margin -72.7% increased compared to -240.0% same period last year
- Net Debt increased by $7.0 mln over the past reporting period (6.8% of market cap)
- FCF (LTM) +$0.0 bln (positive), 5.8% of market cap
- EV/Sales multiple is 3.2x

------------------------------------------------

2024-03-26

#reports #AP

[Ampco-Pittsburgh Corporation](https://eninvs.com/all.php?name=AP) (Metal Fabrication) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=164829)
(2024-03-25, After Market Close):

- Revenue +14.9% YoY (vs +2.0% in previous quarter and historical rate +9.1%)
- EBITDA -1950.0% YoY (vs +1333.3% in previous quarter and historical rate +29.4%)
- EBITDA margin -34.3% decreased compared to 2.1% same period last year
- Net Debt increased by $137.0 mln over the past reporting period (253.0% of market cap)
- FCF (LTM) -$0.0 bln (negative), 33.2% of market cap
- EV/EBITDA multiple is 3.0x compared to historical level (75th percentile) of 19.0x
- EV/Sales multiple is 0.5x

------------------------------------------------

2024-03-23

#reports #VBFC

[Village Bank and Trust Financial](https://eninvs.com/all.php?name=VBFC) (Banks — Regional) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=164811)
(2024-02-26, After Market Close):

- Revenue +75.0% YoY (vs -14.3% in previous quarter and historical rate -1.5%)
- Net Income 0.0% YoY (vs -250.0% in previous quarter and historical rate -7.6%)
- Net Income margin 28.6% decreased compared to 50.0% same period last year
- P/E multiple is 12.2x compared to historical level (75th percentile) of 7.9x
- P/S multiple is 2.4x
- Price to book: 0.9x

The company showed EPS +$1.14 per share

------------------------------------------------

2024-03-23

#reports #SCHL

[Scholastic](https://eninvs.com/all.php?name=SCHL) (Educational products for children manufacturer) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=164796)
(2024-03-21, After Market Close):

- Revenue -0.3% YoY (vs +73.2% in previous quarter and historical rate +20.0%)
- EBITDA -300.0% YoY (vs +34.8% in previous quarter and historical rate +59.0%)
- EBITDA margin -3.7% decreased compared to 1.8% same period last year
- EV/EBITDA multiple is 7.3x compared to historical level (75th percentile) of 11.8x
- EV/Sales multiple is 0.6x

At the opening of the session the share price went down -0.3% vs S&P500 0.0%

------------------------------------------------

2024-03-23

#reports #GLG

[TD](https://eninvs.com/all.php?name=GLG) (Information Technology Services) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=164809)
(2023-08-28):

- Revenue +88.2% YoY (vs -10.5% in previous quarter and historical rate +78.5%)
- EBITDA margin 231.3% increased compared to -517.6% same period last year
- Net Debt increased by $1.2 bln over the past reporting period (38524.5% of market cap)
- FCF (LTM) +$2.1 bln (positive), 66376.2% of market cap
- EV/EBITDA multiple is 8.0x compared to historical level (75th percentile) of 35.0x
- EV/Sales multiple is 8.9x

------------------------------------------------

2024-03-23

#reports #YJ
@ china

[Yunji](https://eninvs.com/all.php?name=YJ) (Internet Retail) reported for 2023 q4
(2023-08-24, Before Market Open):

- Revenue -50.0% YoY (vs -41.2% in previous quarter and historical rate -51.1%)
- EBITDA -20.0% YoY (vs -25.0% in previous quarter)
- EBITDA margin 19.0% increased compared to 11.9% same period last year
- Net Debt decreased by $72.0 mln over the past reporting period (53.5% of market cap)
- FCF (LTM) -$0.0 bln (negative), 11.9% of market cap
- EV/EBITDA multiple is 62.7x compared to historical level (75th percentile) of 127.0x
- EV/Sales multiple is 0.7x

------------------------------------------------

2024-03-22

#reports #ALOT

[AstroNova](https://eninvs.com/all.php?name=ALOT) (Computer Hardware) reported for 2023 q4
(2023-03-23, Before Market Open):

- Revenue +33.3% YoY (vs -2.6% in previous quarter and historical rate +9.3%)
- EBITDA margin 10.0% increased compared to 0.0% same period last year
- Net Debt decreased by $6.0 mln over the past reporting period (4.6% of market cap)
- FCF (LTM) -$0.0 bln (negative), 11.5% of market cap
- EV/EBITDA multiple is 11.3x compared to historical level (75th percentile) of 19.8x
- EV/Sales multiple is 1.0x

At the opening of the session the share price went up +10.9% vs S&P500 +0.6%

------------------------------------------------

2024-03-22

#reports #XBIO

[Xenetic Biosciences](https://eninvs.com/all.php?name=XBIO) (Biotechnology) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=164752)
(2023-08-11, Before Market Open):

- Revenue +38.0% YoY (vs +47.6% in previous quarter and historical rate +78.5%)
- EBITDA margin -419.5% decreased compared to -320.9% same period last year
- Net Debt increased by $793.0 mln over the past reporting period (13136.9% of market cap)
- FCF (LTM) -$4.1 bln (negative), 68152.9% of market cap
- EV/EBITDA multiple is 2.7x compared to historical level (75th percentile) of 6.1x
- EV/Sales multiple is -3.5x

At the opening of the session the share price went up +6.9% vs S&P500 -0.4%

------------------------------------------------

2024-03-22

#reports #WGO

[Winnebago Industries](https://eninvs.com/all.php?name=WGO) (Motorhome manufacturer) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=164751)
(2024-03-21, Before Market Open):

- Revenue +69.2% YoY (vs -19.9% in previous quarter and historical rate +41.1%)
- EBITDA +17.2% YoY (vs -53.1% in previous quarter and historical rate +18.7%)
- EBITDA margin 7.0% decreased compared to 10.0% same period last year
- Net Debt increased by $50.0 mln over the past reporting period (2.4% of market cap)
- FCF (LTM) -$0.0 bln (negative), 0.0% of market cap
- EV/EBITDA multiple is 8.3x compared to historical level (75th percentile) of 6.8x
- EV/Sales multiple is 0.4x

The company showed EPS -$0.43 per share. At the opening of the session the share price went up +3.9% vs S&P500 +0.6%

------------------------------------------------

2024-03-22

#reports #TELA

[TELA Bio](https://eninvs.com/all.php?name=TELA) (Medical Devices) reported for [2023 q4](https://eninvs.com/press_release.php?ticker=TELA&q=2023 q4&id=763311)
(2024-03-21, After Market Close):

- Revenue +41.7% YoY (vs +36.4% in previous quarter and historical rate +48.8%)
- EBITDA margin -70.6% increased compared to -75.0% same period last year
- Net Debt increased by $12.0 mln over the past reporting period (9.2% of market cap)
- FCF (LTM) +$0.0 bln (positive), 26.7% of market cap
- EV/Sales multiple is 2.2x

------------------------------------------------

2024-03-22

#reports #LULU

[Lululemon Athletica](https://eninvs.com/all.php?name=LULU) (Clothes manufacturer) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=164742)
(2024-03-21, After Market Close):

- Revenue +15.6% YoY (vs +18.7% in previous quarter and historical rate +33.1%)
- EBITDA +163.0% YoY (vs -4.2% in previous quarter and historical rate +54.8%)
- EBITDA margin 32.4% increased compared to 14.2% same period last year
- Net Debt decreased by $77.0 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) -$0.1 bln (negative), 0.2% of market cap
- EV/EBITDA multiple is 24.2x compared to historical level (75th percentile) of 34.0x
- EV/Sales multiple is 6.3x

------------------------------------------------

2024-03-22

#reports #IDN

[Intellicheck](https://eninvs.com/all.php?name=IDN) (Software — Application) reported for [2023 q4](https://eninvs.com/press_release.php?ticker=IDN&q=2023 q4&id=763305)
(2024-03-21, After Market Close):

- Revenue 0.0% YoY (vs +25.0% in previous quarter and historical rate +26.5%)
- EBITDA margin 20.0% increased compared to 0.0% same period last year
- EV/Sales multiple is 1.3x

------------------------------------------------

2024-03-22

#reports #HQI

[HireQuest](https://eninvs.com/all.php?name=HQI) (Staffing and Employment Services) reported for [2023 q4](https://eninvs.com/press_release.php?ticker=HQI&q=2023 q4&id=762599)
(2024-03-21, After Market Close):

- Revenue +25.0% YoY (vs 0.0% in previous quarter and historical rate +57.7%)
- EBITDA -78.6% YoY (vs -40.0% in previous quarter and historical rate +60.3%)
- EBITDA margin 30.0% decreased compared to 175.0% same period last year
- Net Debt decreased by $1.0 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.0 bln (positive), 0.6% of market cap
- EV/EBITDA multiple is 14.2x compared to historical level (75th percentile) of 21.8x
- EV/Sales multiple is 4.9x

On post-market the stock shows a growth by +2.2%

------------------------------------------------

2024-03-22

#reports #DERM

[Journey Medical Corporation](https://eninvs.com/all.php?name=DERM) (Drug Manufacturers — Specialty and Generic) reported for [2023 q4](https://eninvs.com/press_release.php?ticker=DERM&q=2023 q4&id=763301)
(2024-03-21, After Market Close):

- Revenue -6.3% YoY (vs +118.8% in previous quarter and historical rate -0.6%)
- EBITDA margin -240.0% decreased compared to -212.5% same period last year
- Net Debt decreased by $8.0 mln over the past reporting period (11.4% of market cap)
- FCF (LTM) +$0.0 bln (positive), 1.4% of market cap
- EV/Sales multiple is 0.8x

On post-market the stock shows a growth by +4.5%

------------------------------------------------

2024-03-22

#reports #BIOL

[BIOLASE](https://eninvs.com/all.php?name=BIOL) (Medical Devices) reported for [2023 q4](https://eninvs.com/press_release.php?ticker=BIOL&q=2023 q4&id=763297)
(2024-03-21, After Market Close):

- Revenue -7.1% YoY (vs -8.3% in previous quarter and historical rate +36.0%)
- EBITDA margin -38.5% increased compared to -57.1% same period last year
- Net Debt decreased by $6.0 mln over the past reporting period (7339.4% of market cap)
- FCF (LTM) -$0.0 bln (negative), 42813.5% of market cap
- EV/Sales multiple is 1.0x

The company showed EPS -$1.76 per share. On post-market the stock shows a growth by +46.7%

------------------------------------------------

2024-03-22

#reports #ARL

[American Realty Investors](https://eninvs.com/all.php?name=ARL) (Real Estate — Development) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=164739)
(2024-04-01):

- Revenue +7.7% YoY (vs +62.5% in previous quarter and historical rate +4.4%)
- EBITDA -20.0% YoY (vs -93.9% in previous quarter)
- EBITDA margin 57.1% decreased compared to 76.9% same period last year
- EV/EBITDA multiple is 60.7x compared to historical level (75th percentile) of 13.4x
- EV/Sales multiple is 7.1x

------------------------------------------------

2024-03-21

#reports #VRME

[VerifyMe](https://eninvs.com/all.php?name=VRME) (Security and Protection Services) reported for 2023 q4
(2024-03-21, Before Market Open):

- Revenue -10.0% YoY (vs +20.0% in previous quarter and historical rate +69.6%)
- EBITDA -14.3% YoY (vs -200.0% in previous quarter)
- EBITDA margin 66.7% decreased compared to 70.0% same period last year
- Net Debt decreased by $2.0 mln over the past reporting period (15.3% of market cap)
- FCF (LTM) -$0.0 bln (negative), 15.3% of market cap
- EV/Sales multiple is 0.6x

At the opening of the session the share price went up +1.9% vs S&P500 +0.6%

------------------------------------------------

2024-03-21

#reports #TITN

[Titan Machinery](https://eninvs.com/all.php?name=TITN) (Industrial Distribution) reported for 2023 q4
(2024-03-21, Before Market Open):

- Revenue +46.1% YoY (vs +3.7% in previous quarter and historical rate +29.1%)
- EBITDA +53.1% YoY (vs -11.5% in previous quarter and historical rate +58.9%)
- EBITDA margin 5.8% increased compared to 5.5% same period last year
- Net Debt increased by $67.0 mln over the past reporting period (11.1% of market cap)
- FCF (LTM) +$0.0 bln (positive), 5.8% of market cap
- EV/EBITDA multiple is 3.4x compared to historical level (75th percentile) of 10.7x
- EV/Sales multiple is 0.3x

At the opening of the session the share price went down -10.7% vs S&P500 +0.6%

------------------------------------------------

2024-03-21

#reports #DXLG

[Destination XL Group](https://eninvs.com/all.php?name=DXLG) (Apparel Retail) reported for 2023 q4
(2024-03-21, Before Market Open):

- Revenue -4.9% YoY (vs -8.5% in previous quarter and historical rate +22.4%)
- EBITDA margin 8.8% increased compared to -1.4% same period last year
- Net Debt decreased by $6.0 mln over the past reporting period (2.8% of market cap)
- FCF (LTM) -$0.0 bln (negative), 3.7% of market cap
- EV/EBITDA multiple is 5.3x compared to historical level (75th percentile) of 9.3x
- EV/Sales multiple is 0.6x

At the opening of the session the share price went down -3.7% vs S&P500 +0.6%

------------------------------------------------

2024-03-21

#reports #DBI

[Designer Brands](https://eninvs.com/all.php?name=DBI) (Apparel Retail) reported for 2023 q4
(2024-03-21, Before Market Open):

- Revenue -0.9% YoY (vs -9.1% in previous quarter and historical rate +11.9%)
- EBITDA -1900.0% YoY (vs -102.9% in previous quarter)
- EBITDA margin -4.8% decreased compared to 0.3% same period last year
- Net Debt increased by $18.0 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) -$0.1 bln (negative), 15.9% of market cap
- EV/EBITDA multiple is 27.2x compared to historical level (75th percentile) of 17.0x
- EV/Sales multiple is 0.7x

At the opening of the session the share price went down -15.7% vs S&P500 +0.6%

------------------------------------------------

2024-03-21

#reports #ABSI

[Absci Corporation](https://eninvs.com/all.php?name=ABSI) (Biotechnology) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=164734)
(2024-03-20, Before Market Open):

- EBITDA margin -2100.0% decreased compared to -1250.0% same period last year
- Net Debt increased by $14.0 mln over the past reporting period (3.0% of market cap)
- FCF (LTM) -$0.0 bln (negative), 9.6% of market cap
- EV/Sales multiple is 77.5x

------------------------------------------------

2024-03-21

#reports #YI
@ china

[Yi Technology](https://eninvs.com/all.php?name=YI) (Pharmaceutical Retailers) reported for [2023 q4](https://eninvs.com/press_release.php?ticker=YI&q=2023 q4&id=763256)
(2024-03-21, Before Market Open):

- Revenue -3.7% YoY (vs +6.6% in previous quarter and historical rate +25.3%)
- EBITDA -140.0% YoY (vs -1900.0% in previous quarter and historical rate -10.7%)
- EBITDA margin -0.7% decreased compared to 1.7% same period last year
- Net Debt increased by $25.0 mln over the past reporting period (19.6% of market cap)
- FCF (LTM) -$0.0 bln (negative), 7.1% of market cap
- EV/Sales multiple is 0.1x

At the opening of the session the share price went down -7.2% vs S&P500 +0.6%

Switch to company model in classical logic    *